Results 121 to 130 of about 14,994 (162)

UnderstandingPlasmodium vivaxrecurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification

open access: yes
Rosado J   +13 more
europepmc   +1 more source

Within-host modelling of primaquine-induced haemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers

open access: yes
Watson JA   +17 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Primaquine overdose in a toddler

The American Journal of Emergency Medicine, 2021
Antimalarial medications carry a risk of rare, but serious side effects. Primaquine in particular is known to cause methemoglobinemia and hemolytic anemia. In patients with underlying glucose-6-phosphate dehydrogenase (G6PD) deficiency, these side effects become amplified and can be life-threatening.
William Schaeffer   +3 more
openaire   +2 more sources

Primaquine and methemoglobin

Clinical Pharmacology & Therapeutics, 1964
Methemoglobin formation occurring as a toxic manifestation of primaquine was studied in volunteers to determine whether or not it is an example of genetic polymorphism. No evidence of polymorphism was found.
David A. Price Evans, W. K. Cowan
openaire   +3 more sources

High dose of primaquine in primaquine resistant vivax malaria

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994
The efficacy of low dose chloroquine, characteristic pattern of relapse and the relapse rate in vivax malaria after high dose primaquine were investigated in 167 Thai patients. 87 patients were allocated at random to receive 300 mg, and 80 received 450 mg of chloroquine on the first day of admission.
Kesara Na Bangchang   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy